<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>319</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15112296</PubmedId>
            <Abstract>Two characteristic monoclonal antibodies (HpU-2 and -18) out of 26 monoclonal antibodies (HpU-1 approximately 26) produced against Helicobacter pylori (H. pylori) urease showed a strong inhibitory effect against the enzymatic activity of the urease. Epitope mapping about some monoclonal antibodies of the HpU-series inhibiting enzymatic activity was performed by using a surface plasmon resonance apparatus and by digesting H. pylori urease with trypsin, followed by mass spectroscopy. The sequences of the epitopes recognized by HpU-2 and -18 were SVELIDIGGNRRIFGFNALVDR (22 mer) and IFGFNALVDR (10 mer), respectively. The former sequence is present as a part of a loop structure at a position close to the C-terminal of the alpha-subunit of H. pylori urease, although it has been suggested that the active site of the urease resides in the beta-subunit. The above peptide (22 mer) was chemically synthesized in a linear and cyclic form, and its conjugate with BSA was immunized in rabbits. The resultant serum induced by the linear form could specifically bind to H. pylori infecting human gastric mucosa. These results suggest that the above sequence (22 mer) must be an important epitope, although it locates in the alpha-subunit but not in the beta-subunit.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>434-44</ArticlePages>
            <ArticleTitle>Epitope mapping and features of the epitope for monoclonal antibodies inhibiting enzymatic activity of Helicobacter pylori urease.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Fujii</LastName>
                    <ForeName>Ryoji</ForeName>
                </Author>
                <Author>
                    <LastName>Morihara</LastName>
                    <ForeName>Fumiko</ForeName>
                </Author>
                <Author>
                    <LastName>Oku</LastName>
                    <ForeName>Takashi</ForeName>
                </Author>
                <Author>
                    <LastName>Hifumi</LastName>
                    <ForeName>Emi</ForeName>
                </Author>
                <Author>
                    <LastName>Uda</LastName>
                    <ForeName>Taizo</ForeName>
                </Author>
            </Authors>
            <Affiliations>Fukuyama Medical Laboratory Company, Fukuyama-city, Hiroshima 720-8510, Japan.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Epitopes;Immune Sera;Peptides, Cyclic;Urease</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Monoclonal(chemistry; immunology; pharmacology); Antibody Specificity; Epitope Mapping(methods); Epitopes(immunology); Gastric Mucosa(microbiology); Helicobacter Infections(microbiology); Helicobacter pylori(enzymology); Humans; Immune Sera; Immunohistochemistry(methods); Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Sequence Data; Peptides, Cyclic(chemistry; immunology); Protein Conformation; Rabbits; Urease(antagonists &amp; inhibitors; immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>86</Volume>
                <Issue>4</Issue>
                <Title>Biotechnology and bioengineering</Title>
                <Issn>1097-0290</Issn>
                <MedlineTa>Biotechnol Bioeng</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Short peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IFGFNALVDR</LinearSequence>
                        <StartingPosition>195</StartingPosition>
                        <EndingPosition>204</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P14916.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>210</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>26075</EpitopeId>
                <ReferenceStartingPosition>194</ReferenceStartingPosition>
                <ReferenceEndingPosition>204</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This epitope is present as a part of a loop structure at a position close to the C-terminal of the a-subunit of H. pylori urease.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6A</LocationOfData>
                        <BCellId>7531</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SVELIDIGGNRRIFGFNALVDR</LinearSequence>
                                            <StartingPosition>183</StartingPosition>
                                            <EndingPosition>204</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P14916.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>210</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>LP</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>P02769.4</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>5</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was constructed as a cyclic peptide in order to effectively induce the desired immune response.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>38</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The cyclic peptide could induce antiserum against H. pylori urease with a much lower titer than seen with the Long-peptide.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Urease alpha subunit</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P14916.2</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>210</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>223</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SVELIDIGGNRRIFGFNALVDR</LinearSequence>
                                            <StartingPosition>183</StartingPosition>
                                            <EndingPosition>204</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P14916.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>210</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>LP</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>P02769.4</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The LP-polyclonal antibodies showed similar reactivity to H. pylori as seen with serum obtained from animals immunized with urease.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Helicobacter pylori</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>210</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4A</LocationOfData>
                        <BCellId>220</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SVELIDIGGNRRIFGFNALVDR</LinearSequence>
                                            <StartingPosition>183</StartingPosition>
                                            <EndingPosition>204</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P14916.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>210</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>LP</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>P02769.4</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>5</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Boosters were given in Incomplete Freund'Âs Adjuvant (IFA) at 2-week intervals.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>LP-polyclonal (affinity-purified) serum reacted with H. pylori urease by a factor of over 10-fold (the estimated affinity constant is about 10&lt;sup&gt;-10&lt;/sup&gt;/M) stronger than to the antigenic Long-peptide.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>LP</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SVELIDIGGNRRIFGFNALVDR</LinearSequence>
                                        <StartingPosition>183</StartingPosition>
                                        <EndingPosition>204</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P14916.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>210</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>7530</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>210</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Helicobacter pylori</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>193</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Affinity chromatography of trypsin-digested urease from H. pylori was carried out with the HpU-2 or -18 Mab.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Hpu-2</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Short peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IFGFNALVDR</LinearSequence>
                                        <StartingPosition>195</StartingPosition>
                                        <EndingPosition>204</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P14916.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>210</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

